Article
The risk of breast cancer associated with dietary lignans differs by CYP17 genotype in women.
The Journal of nutrition - 1 Oct 2002
McCann Susan E, Moysich Kirsten B, Freudenheim Jo L, Ambrosone Christine B, Shields Peter G
Abstract excerpt
Lignans are plant compounds metabolized in the gut to produce the phytoestrogens enterolactone and enterodiol. Reduced breast cancer risks associated with higher urinary lignan excretion may be related to competitive inhibition of endogenous estrogens. Evidence exists that associations with reproductive risk factors for breast cancer differ according to cytochrome P450c17alpha (CYP17) genotype. Genetic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
